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Complexes of transition metals with amino acids in proteins and peptides are uti-
lized in numerous biological processes, such as oxygen transport, electron transfer and
oxidation. In these processes, the enzymatic active site, which is very specific, often in-
cludes several histidine residues, which form complexes with divalent metal ions.
Histidine is involved in the coordination of copper ions in several copper proteins,
including superoxide dismutase, ceruloplasmin, ascorbate oxidase, etc. In addition, hi-
stidine is thought to be involved in the transport of copper into cells in vivo, from albu-
min. Copper(II)-histidine complexes have been thoroughly investigated (1–3) and the
structure and charge of the complexes have been defined (4–7). A notable review of the
copper(II)-histidine complex stability constants and charge can be found (8). According
to these concepts, the most probable structure of the complex is Cu(His)2 (Fig. 1).
105
Acta Pharm. 56 (2006) 105–112 Short communication
Properties of the copper(II)-histidine complex obtained after





1Sofia University, Faculty of Chemistry




Aberdeen, AB21 9SB, UK
Accepted October 10, 2005
The copper(II)-histidine complex obtained following di-
alysis of human plasma with histidine was investigated
using various types of extraction systems and ion ex-
change resins. According to the results obtained, the
Cu(II)-histidine complex formed under the dialysis con-
ditions has one positive charge. Preconcentration of cop-
per from the dialysis solution was achieved by its extrac-
tion as a dithiocarbamate complex and by sorption on
cation-exchange resin or onto chelate sorbent.
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Fig. 1. Structure of the copper(II)-histidine complex.
It is known that L-histidine can remove copper from albumin. Based on the differ-
ence in the stability constants of both Cu-albumin and Cu-histidine complexes (9), a
method to extract Cu2+ from blood plasma based on dialysis in the presence of histidine
has been devised (10–12). In our previous studies we have demonstrated the validity of
this method for the determination of exchangeable copper in human plasma (10–13).
However, some properties and experimental observations of the Cu(II)-histidine com-
plex formed under dialysis conditions could not be explained. We proposed that the
copper(II)-histidine complex in the dialysis solution might not be in the form of the much
described Cu(His)2 form, as expected, but rather as a more complex, non-stoichometric
substance. Besides, the formed complex may not be neutral, but charged.
The aim of the present work was to study the properties of the copper(II)-histidine
complex formed during dialysis of human plasma with histidine. For this purpose, vari-
ous extraction and sorption systems were applied and evaluated.
The research was conducted under a protocol approved by the Norwick (UK) Dis-
tricts Ethics Committee and written consent of the volunteers was obtained. Six healthy
male subjects aged 34–57 years (non-smokers, not taking medications or nutritional sup-
plements) were included in the study. Their biological and hematological indices fell in-
side the normal range.
EXPERIMENTAL
Instrumentation
Atomic absorption spectrophotometry (AAS) measurements were carried out using
a Pye Unicam 1950 atomic absorption spectrometer (UK) with an air/acetylene flame.
The flow rates were 5 L min–1 for air and 1 L min–1 for acetylene. The light source used
was a Unicam hollow cathode lamp for Cu and the measurements were performed at
324.7 nm. The spectral bandpass was 0.2 nm. pH values were determined with a Consort
Model P800 pH meter (Belgium) using a combination electrode.
Reagents
All reagents and solvents were of analytical-reagent grade. Dowex 50-X8 (50–100 mesh,
hydrogen form, Merck, Germany) and Chelex-100 (200–400 mesh, Na form, Bio-Rad, UK)
resins were commercially available. Standard solutions for Cu in organic solvent were
prepared from multi-element standard oil solution (p.a., Merck) by dilution with i-butyl
methyl ketone (IBMK). Aqueous standard solutions of Cu2+ were prepared by appropri-
ate dilution of a stock solution (1 g L–1 Cu in 0.2% HNO3, BDH (UK) standard solutions
for AAS). For Ca and Mg analysis, BDH standard solutions for AAS (1 g L–1) were also
used. L-histidine was purchased from Sigma Scientific, UK. Beckman standard solution
(120 mmol L–1 Na, 2 mmol L–1 K, Beckman Instruments, USA), ammonium pyrrolidi-
nedithiocarbamate (APDC, p.a., Merck, 1% aqueous solution), NH4H2PO4 (p.a., Merck),
IBMK (p.a. Merck), sodium dodecylsulphonate (NaDDS, p.a., Merck, 0.001 mol L–1 aque-
ous solution) and tetraoctylmethyl ammonium chloride (TOMACl, p.a., Merck, 2% solu-
tion in IBMK) were used as received. Doubly distilled water was used throughout.
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Dialysis procedure
Spectrapore dialysis tubing (10 mm flat with cellulose ester membrane, MWCO 5000,
Spectrum Europe B.V., The Netherlands) was soaked in 50 mmol L–1 histidine solution,
followed by at least 2 changes of water. To each of the clipped lengths of tubing, 5 mL of
human plasma was added. After clipping the top of the tubes, the open end into which
the sample was pipetted was rinsed to remove any residual sample. Using acid-cleaned
100 mL measuring cylinders, all the samples were dialyzed against 100 mL of 175 mmol
L–1 ammonium phosphate buffer, pH 7.0, for 4 hours. All samples were then dialyzed
against 2 × 100 mL of 175 mmol L–1 ammonium phosphate buffer, pH 7.0, containing 50
mmol L–1 of histidine, for 4 h and the dialysates were collected. The copper concentra-
tion in all acidified solutions was analyzed by AAS using standards prepared with 10%
nitric acid.
Preparation of a model solution containing the Cu-histidine complex
In order to mimic the physiological levels of trace elements in human plasma,
appropriate aliquots of 100 mg L–1 of Cu2+, Ca2+ and Mg2+ were added to obtain final
concentrations of copper, calcium and magnesium of 1 mg L–1, 60 mg L–1 and 37 mg L–1,
respectively. Finally, NH4H2PO4 and L-histidine were added to achieve final concentra-
tions of 20 g L–1 and 7.8 g L–1, respectively, in order to mimic the dialysis condition (12).
Solvent extraction
Thirty milliliters of the dialysate or of the model solution was transferred into a 30.0
mL extraction tube. The steps depended on the extraction system applied are shown in
Table I.
After finishing the extraction, the organic phase was directly aspirated into the flame
of the spectrometer and the copper absorption was recorded against organic standard
solutions for Cu in IBMK.
Column solid phase extraction
Dowex 50-X8. – A column containing Dowex 50-X8 resin (0.5 g) was treated with 30
mL of 0.2 mol L–1 HNO3 followed by distilled water to wash. The resin was conditioned
by passing 10 mL of 0.4 mol L–1 HCl (flow rate 2 mL min–1) followed by doubly distilled
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Table I. Solvent extraction systems
Aqueous phase Organic phase, volume (mL) Contact time (min)
Cu(II)-histidine IBMK, 2.0 5
Cu(II)-histidine + APDC (1.0 mL of 1%) IBMK, 2.0 2
Cu(II)-histidine + NaDDS (0.01–0.05 mL
of 0.001 mol L–1)
IBMK, 2.0 5
Cu(II)-histidine 2% TOMACl in IBMK, 2.0 5
water until the pH of the eluate reached 7.0. Then 100 mL of the model solution was
passed through the column at a flow rate of 2 mLmin–1. Eluate fractions of 10.0 mLwere
collected and the concentration of Cu in these fractions was determined by flame AAS.
Before elution, the resin was washed with 10 mL doubly distilled water. Copper was
eluted from the resin using 4 mol L–1 HCl at a flow rate of 2 mL min–1. The copper con-
centration was measured in 2.0 mL fractions of eluate.
Chelex-100. – A column containing 1 g Chelex-100 resin (styrene divinyl benzene co-
polymer with iminodiacetate functional groups) was washed with 20 mL 2.5 mol L–1 ni-
tric acid and 30 mL of doubly distilled water. The resin was conditioned by passing 20 mL
of 1 mol L–1 ammonium acetate (pH 5.5). Then 100 mL of model solution of Cu(II)-histidine
was passed through the column at a flow rate of 2 mL min–1. Eluate fractions of 10.0 mL
were collected and Cu concentration was determined by flame AAS. The column was
washed with 20 mL doubly distilled water to remove any remaining matrix components.
Copper was eluted from the resin using 2.5 mol L–1 HNO3 at a flow rate of 2 mL min–1.
The concentration of Cu was measured in each 2 mL of eluate.
RESULTS AND DISCUSSION
Investigation of the extraction properties of the copper(II)-histidine complex gives
information about (i) the charge of the Cu(II)-histidine complex formed during the dial-
ysis process, and (ii) the potential for preconcentration of copper from the dialysis solu-
tion.
In the case the investigated complex was neutral, a quantitative extraction of Cu(His)2
into organic solvent as IBMK was expected. The results presented in Table II show that
less than 1% of the complex was extracted, and hence it was not neutral. A negative
charge of the complex would predict high extraction recovery when a long chain quater-
nary ammonium salt as TOMACl, dissolved in IBMK, is used as positively charged co-
unter ion. It is obvious from the results presented in Table II that no formation of an ion
associate complex took place and that it was therefore not negatively charged. Quantitative
extraction of Cu(II)-histidine complex into IBMK was achieved only with a big organic
dodecylbenzenesulphonate anion as counter-ion and the formation of an extractable ion
associate complex. This shows that the complex was positively charged. This conclusion
was further confirmed by investigations of the sorption properties of the Cu(II)-histidine
complex using the cation exchange resin Dowex 50-X8 (Fig. 2).
Cation exchange was observed for the model solution and dialysate when using the
resin prepared in the H+ form (dynamic capacity 160 mg g–1 Cu2+) and in the Na+ form
(dynamic capacity 180 mg g–1 Cu2+). No ion exchange was observed when the resin Do-
wex 50-X8 was in Ca2+ form. It may be deduced from this information that the complex
bears a positive charge of +1. It could be also deduced that one mol of the copper(II)-
-histidine complex interacts with one mol dodecylsulfonate (DDS) anion to form an ion
associate. To prove this assumption, the equilibrium shift method was applied to deter-
mination of the composition of the extracted ion associate. The extraction equilibria can
be presented as:
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Cu-Hisn+aq + n DDS–aq →← [(Cu-His)(DDS)n]org
The equilibrium constant, Kex:
Kex = [(Cu-His)(DDS)n]org/[ Cu-Hisn+]aq [DDS-]naq
The distribution coefficient, D:
D = [(Cu-His)(DDS)n]org/[Cu-Hisn+]aq
or
log D = log Kex + n log [DDS–]aq
The concentration of DDS was varied in the range 1.5 × 10–5 – 3 × 10–6 mol L–1 and
the log D was calculated measuring the copper concentration in the organic and in the
aqueous phase. The results are graphically presented in Fig. 3.
It can be seen that one mole Cu-histidine forms an ion associate with one mole DDS
(n = 1); hence the charge of the Cu-histidine complex is +1.
Extraction preconcentration of copper from dialysis solutions is possible after trans-
formation of the Cu(II)-histidine complex into a neutral copper pyrrolidinedithiocarba-
mate chelate complex Cu(PDC)2. This transformation is possible due to the higher sta-
bility of Cu(PDC)2 (b = 1028) compared to the Cu(II)-histidine complex (b = 1017). The
extraction of Cu is quantitative (recovery > 99%) for a broad range of pH values (6 to 10,
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Copper concentration (mg L )–1
Dowex 50-X8 in H-form
Dowex 50-X8 in Na-form
Dowex 50-X8 in Ca-form
Fig. 2. Adsorption profiles of
the Cu(II)-histidine standard
solution on Dowex 50-X8 re-
sin in different forms (mean
± SD, n = 3).
Table II) and for a ratio of aqueous to organic phase of up to 50 : 3. This equates to a
17-fold extraction preconcentration. This preconcentration procedure showed higher pre-
cision and ruggedness. RSD for the recovery obtained on different days by different op-
erators, in different laboratories, with different batches of reagents varied between 0.2
and 1%) than extraction of copper as Cu-histidine-DDS complex (RSD under reprodu-
cibility conditions as previously mentioned varied between 3 and 8%).
Dowex 50-X8 resin (H+-form, 0.5 g resin) can be used for quantitative sorption of up
to 80 µg copper as the Cu(II)-histidine complex (Fig. 2). The large excess of Ca2+ and
Mg2+ in the dialysis solution reduces the amount of copper absorbed, due to limited dy-
namic ion exchange capacity. For quantitative elution, 14 mL of 4 mol L–1 HCl are neces-
sary (Fig. 4).
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Fig. 3. Equilibrium shift method
for determination of the compo-
sition of the extracted ion associ-
ate (Cu-His) (DDS)n (cCu = 3× 10–6
mol L–1, cNaDDS = 1.5 × 10–5 – 3 ×
10–6 mol L–1); n – moles of DDS–
(mean ± SD, n = 4).
Table II. Extractability of Cu(II) from dialysis solution in dependence on the extraction system
[copper as Cu(II)-histidine complex]
Extraction system Extraction recovery (%)
IBMK < 1 %
TOMACl/IBMK < 1 %












a Mean ± SD, n = 3.
Another proposed method for preconcentrating copper from the dialysis solutions
utilizes the chelate sorbent Chelex-100. Quantitative sorption of up to 100 mg copper is
achieved from dialysis solutions with pH 5–7. Quantitative elution follows with 14 mL
of 2.5 mol L–1 HNO3 (Fig. 4).
CONCLUSIONS
The study of the extraction and sorption of the Cu(II)-histidine complex onto ion ex-
change resins leads to the conclusion that the copper(II)-histidine complex formed dur-
ing the dialysis of human plasma is positively charged and bears a single positive charge.
The extraction of ion associates, and of neutral Cu(II)-pyrrolidinedithiocarbamate chela-
te into IBMK as well as sorption onto cation exchange resin or onto chelate sorbent can
be used for preconcentration of copper from the dialysis solution.
The investigations performed also help to study the speciation of copper binding to
proteins in human plasma, to study the kinetics of copper turnover in exchangeable and
non-exchangeable plasma copper fractions. It leads to a better understanding of the hu-
man copper metabolism, to a more precise estimation of dietary requirements and of the
risk of copper intoxication.
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S A @ E T A K
Svojstva bakar(II)-histidin kompleksa izoliranog iz dijalizirane humane plazme
s histidinom
TONY VENELINOV, SONIA ARPADJAN, IRINA KARADJOVA i JOHN BEATTIE
U radu su ispitivani razli~iti sustavi za ekstrakciju i ionske-izmjenjiva~ke smole za
izolaciju bakar(II)-histidin kompleksa iz dijalizirane humane plazme s histidinom. Prema
dobivenim rezultatima, bakar(II)-histidin kompleks ima jedan pozitivan naboj. Prekon-
centracija bakra iz otopine za dijalizu postignuta je ekstrakcijom ditiokarbamatnog kom-
pleksa i sorpcijom na kation-izmjenjiva~ku smolu ili stvaranjem kelata.
Klju~ne rije~i: bakar-histidin, dijaliza humane plazme, ekstrakcija, ionska izmjena
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